This European Drug Agency paper analyses how drug production in Afghanistan evolved under the Taliban drug ban, focusing on heroin and methamphetamine. It documents shifts in the trade and processing of key drugs like ephedra, ephedrine, methamphetamine, opium, morphine and heroin.


